Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Capital Expenditures (2016 - 2026)

Bruker filings provide 16 years of Capital Expenditures readings, the most recent being $22.6 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 38.42% to $22.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $90.8 million, a 21.25% decrease, with the full-year FY2025 number at $90.8 million, down 21.25% from a year prior.
  • Capital Expenditures hit $22.6 million in Q4 2025 for Bruker, up from $20.9 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $57.7 million in Q3 2022 to a low of $16.3 million in Q3 2021.
  • Median Capital Expenditures over the past 5 years was $24.6 million (2021), compared with a mean of $26.7 million.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 253.99% in 2022 and later plummeted 53.38% in 2023.
  • Bruker's Capital Expenditures stood at $28.4 million in 2021, then increased by 21.83% to $34.6 million in 2022, then fell by 8.96% to $31.5 million in 2023, then grew by 16.51% to $36.7 million in 2024, then crashed by 38.42% to $22.6 million in 2025.
  • The last three reported values for Capital Expenditures were $22.6 million (Q4 2025), $20.9 million (Q3 2025), and $21.3 million (Q2 2025) per Business Quant data.